Aerie Pharmaceuticals, Inc. (AERI) Analysts See $-0.89 EPS; Trinseo S.A. Ordinary Shares (TSE) SI Increased By 0.69%

April 26, 2018 - By Stephen Andrade

Trinseo S.A. (NYSE:TSE) Logo

Trinseo S.A. Ordinary Shares (NYSE:TSE) had an increase of 0.69% in short interest. TSE’s SI was 803,400 shares in April as released by FINRA. Its up 0.69% from 797,900 shares previously. With 385,600 avg volume, 2 days are for Trinseo S.A. Ordinary Shares (NYSE:TSE)’s short sellers to cover TSE’s short positions. The SI to Trinseo S.A. Ordinary Shares’s float is 1.84%. The stock decreased 0.26% or $0.2 during the last trading session, reaching $75.6. About 306,632 shares traded. Trinseo S.A. (NYSE:TSE) has risen 14.64% since April 26, 2017 and is uptrending. It has outperformed by 3.09% the S&P500.

Analysts expect Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to report $-0.89 EPS on May, 1.They anticipate $0.13 EPS change or 17.11% from last quarter’s $-0.76 EPS. After having $-1.38 EPS previously, Aerie Pharmaceuticals, Inc.’s analysts see -35.51% EPS growth. The stock increased 0.46% or $0.25 during the last trading session, reaching $54.2. About 149,539 shares traded. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 16.25% since April 26, 2017 and is uptrending. It has outperformed by 4.70% the S&P500.

Trinseo S.A., a materials company, manufactures and markets synthetic rubber, latex binders, and plastic products in Europe, North America, Latin America, and the Asia Pacific. The company has market cap of $3.27 billion. The firm operates through Latex Binders, Synthetic Rubber, Performance Plastics, Basic Plastics, Feedstocks, and Americas Styrenics divisions. It has a 10.36 P/E ratio. The Latex Binders segment offers styrene-butadiene, styrene-acrylate, vinylidene chloride, and butadiene-methacrylate latex products for the commercial and niche carpet markets, as well as performance latex products for the adhesive, building and construction, and technical textile paper markets.

Among 6 analysts covering Trinseo (NYSE:TSE), 4 have Buy rating, 0 Sell and 2 Hold. Therefore 67% are positive. Trinseo had 28 analyst reports since August 6, 2015 according to SRatingsIntel. As per Monday, August 7, the company rating was maintained by Citigroup. The firm has “Buy” rating by Alembic given on Wednesday, August 2. The stock of Trinseo S.A. (NYSE:TSE) earned “Buy” rating by Jefferies on Monday, August 28. The firm has “Buy” rating by Zacks given on Thursday, August 6. The rating was maintained by Barclays Capital with “Equal-Weight” on Thursday, February 1. The stock of Trinseo S.A. (NYSE:TSE) earned “Outperform” rating by Wells Fargo on Wednesday, February 21. Citigroup maintained Trinseo S.A. (NYSE:TSE) rating on Monday, April 18. Citigroup has “Neutral” rating and $45 target. The firm earned “Buy” rating on Friday, October 6 by Jefferies. The stock of Trinseo S.A. (NYSE:TSE) earned “Buy” rating by Wells Fargo on Wednesday, January 17. Jefferies maintained the stock with “Buy” rating in Friday, March 31 report.

Investors sentiment decreased to 1.2 in 2017 Q4. Its down 0.53, from 1.73 in 2017Q3. It turned negative, as 23 investors sold Aerie Pharmaceuticals, Inc. shares while 48 reduced holdings. 21 funds opened positions while 64 raised stakes. 34.86 million shares or 1.29% more from 34.42 million shares in 2017Q3 were reported. Senzar Asset Management Limited Company holds 4.25% or 278,400 shares in its portfolio. Moreover, Tiaa Cref Inv Management Ltd Liability Corporation has 0% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Alyeska Investment Grp Incorporated L P reported 136,127 shares. Citadel Advisors invested in 0% or 34,903 shares. Northern Trust Corporation has invested 0.01% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Driehaus Mgmt Ltd Co holds 75,995 shares or 0.17% of its portfolio. Partner Invest Mgmt Limited Partnership holds 2.32% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) or 33,688 shares. Prudential Financial Inc has invested 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Price T Rowe Assocs Md accumulated 327,671 shares or 0% of the stock. Orbimed Advsr Ltd Com invested 1% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Swiss Bank owns 0% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 52,600 shares. Sg Americas Lc has invested 0.01% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). 4,094 were accumulated by Trexquant Inv L P. Wells Fargo And Mn has 22,991 shares for 0% of their portfolio. Bamco reported 0% in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI).

Trinseo S.A. (NYSE:TSE) Ratings Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.





Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts